ONEDAY BIOTECH CO., LTD – Trademark Portfolio

Entity Type: 99

ONEDAY BIOTECH CO., LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include 1. The owner is based in Daegu.

(Woram-dong)

C-dong, 135 Seongseodong-ro, Dalseo-gu

Daegu 42721 , KR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

1
1
Registered 2023

Trademark Classifications

ONEDAY BIOTECH CO., LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ONEDAY BIOTECH CO., LTD have?

ONEDAY BIOTECH CO., LTD has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does ONEDAY BIOTECH CO., LTD file in?

ONEDAY BIOTECH CO., LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ONEDAY BIOTECH CO., LTD's most well-known trademarks?

ONEDAY BIOTECH CO., LTD's registered trademark portfolio includes well-known marks such as 1. These are among 1 currently registered trademark in the portfolio.

What is ONEDAY BIOTECH CO., LTD's trademark registration success rate?

ONEDAY BIOTECH CO., LTD has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.